|
20 Jun 2007 |
ConjuChem Biotechnologies Reports PC-DAC(TM):Exendin-4 Albumin Conjugate Data Presented at American Diabetes Association Annual Meeting
|
|
19 Jun 2007 |
Advanced Viral Research Corp. Announces Positive Preliminary Findings from Ongoing Phase II Dermatological Study
|
|
19 Jun 2007 |
Presentation of In Vivo HDL Kinetic Data at the European Atherosclerosis Society 76th Congress Demonstrates Activation of Reverse Cholesterol Transport by Pre-Beta HDL in Selectively Delipidated
|
|
16 Jun 2007 |
Novo Nordisk and Neose announce initiation of phase 1 clinical trial of long-acting factor VIIa
|
|
15 Jun 2007 |
Fabry Study Demonstrates Sustained, Long-Term Renal Stabilization After 54 Months
|
|
13 Jun 2007 |
IBPL Becomes Country's First Dedicated Biopharmaceutical Facility to Receive EU-GMP Certification
|
|
13 Jun 2007 |
Eurand Files NDA for Zentase(TM) for Exocrine Pancreatic Insufficiency
|
|
12 Jun 2007 |
Phase III clinical trial with 4-month long-acting formulation of triptorelin: Ipsen decides not to perform further administration
|
|
12 Jun 2007 |
Altus Pharmaceuticals Reacquires European Development and Commercialization Rights to ALTU-135
|
|
09 Jun 2007 |
Scios Announces Enrollment of First Patients in Ascend-HF
|
|
08 Jun 2007 |
Alkermes Announces Initiation of Phase I Clinical Study of AIR(R) Parathyroid Hormone
|
|
08 Jun 2007 |
Discovery Labs Initiates Phase 2 Clinical Trial in Children with Acute Respiratory Failure
|
|
08 Jun 2007 |
Human Genome sciences announces positive final results of Phase 2b trial of Albuferon(R)
|
|
08 Jun 2007 |
Lipid Sciences Announces Validation of Proprietary Peptide That Mimics Key Functions of Natural Human HDL
|
|
06 Jun 2007 |
Unigene Reports That Oral Calcitonin Phase III Clinical Study for Osteoarthritis Treatment is Initiated
|
|
05 Jun 2007 |
Merck at ASCO 2007: Encouraging Results in Progression-Free Survival in Patients With Aggressive Brain Tumors (glioblastoma) Using Cilengitide in Phase I/IIa Study
|
|
05 Jun 2007 |
SciClone's SCV-07 Inhibits Melanoma Tumor Growth in Animal Model Study
|
|
05 Jun 2007 |
ONTAK(R) (denileukin diftitox) Achieves 49.1% Overall Response Rate in
|
|
04 Jun 2007 |
Xanthus announces Phase 1 results for P2045 - a targeted agent for nonsmall cell lung cancer
|
|
03 Jun 2007 |
Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III Melanoma Demonstrated Significant and Sustained Impact on Relapse-Free Survival
|
|
01 Jun 2007 |
Indevus Announces Authorization for Approval of VANTAS(R) in Selected European Countries
|
|
01 Jun 2007 |
Hemispherx Presents Potential Avian Influenza Treatment Breakthrough at Paris Conference
|
|
01 Jun 2007 |
Cytheris to start two phase I/IIa clinical trials of CYT107, its new recombinant Interleukin-7, in Hepatitis C and oncology
|
|
01 Jun 2007 |
Presentations at 2007 European Stroke Congress Highlights New Direction for Viprinex(TM) (ancrod)
|
|
01 Jun 2007 |
Lev Pharmaceuticals Completes Phase III Prophylaxis Trial of C1-Esterase Inhibitor for Hereditary Angioedema
|
